Cerity Partners LLC Atai Life Sciences N.V. Transaction History

Cerity Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.27 - $2.6 $4,517 - $9,248	-3,557 Reduced 6.9%	47,965 $63,000
Q1 2024 May 14, 2024	SELL	$1.5 - $2.19 $69,664 - $101,710	-46,443 Reduced 47.41%	51,522 $101,000
Q4 2023 Jan 26, 2024	SELL	$1.04 - $1.55 $148,380 - $221,144	-142,674 Reduced 59.29%	97,965 $138,000
Q3 2023 Nov 13, 2023	SELL	$1.27 - $2.28 $869,137 - $1.56 Million	-684,360 Reduced 73.98%	240,639 $310,000
Q2 2023 Aug 14, 2023	SELL	$1.44 - $2.19 $603,648 - $918,048	-419,200 Reduced 31.19%	924,999 $1.59 Million
Q4 2022 Feb 15, 2023	BUY	$2.38 - $3.55 $3.2 Million - $4.77 Million	1,344,199 New	1,344,199 $3.58 Million

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.